Our current study reveals a novel paradigm in m6A‐modified lncRNAs controlling CSDE1‐mediated oncogenic RNA regulons and highlights lncRNAs as potential targets for future therapeutics against HCC. The gene discussed is CSDE1; the disease is hepatocellular carcinoma.